(Q56908618)

English

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity

scientific article published on 18 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

0 references

1 reference

based on heuristic

inferred from title

Paul Whi Parren

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

C Kellner

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

D Hallack

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

P Glorius

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Staudinger

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

S Mohseni Nodehi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M de Weers

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

J G J van de Winkel

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Stauch

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

T Valerius

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

R Repp

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

A Humpe

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Gramatzki

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Peipp

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

18 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

830-834

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

https://scigraph.springernature.com/pub.10.1038/leu.2011.288

0 references

Up on the tightrope: natural killer cell activation and inhibition

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

NKG2D ligands in tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.288

21 January 2018

Identifiers

10.1038/LEU.2011.288

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005785%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56908618&oldid=2152563935"